A Study of Bio-008 in Subjects With Advanced or Metastatic Solid Tumours

Clinical trial NCT06027346 · UNKNOWN

Trial details

NCT number: NCT06027346
Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2023-07-17
Primary completion: 2026-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.